Ciencias Biomédicas
Departamento
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (4)
2017
-
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
New England Journal of Medicine, Vol. 377, Núm. 13, pp. 1228-1239
2016
-
An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies
Drug Safety, Vol. 39, Núm. 1, pp. 29-43
-
Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project
Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 156-165
-
The IMI PROTECT project: Purpose, organizational structure, and procedures
Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 5-10